Christian Shults, MD, is a cardiac surgeon at MedStar Washington Hospital Center. He is the regional director of cardiac aortic surgery, surgical ablation, and innovation, as well as the fellowship director for the complex aortic structural heart program. He is also an assistant professor of surgery at Georgetown University School of Medicine. Dr. Shults is board certified in general and thoracic surgery.
Dr. Shults specializes in the treatment of complex aortic disease, structural heart disease, valvular disease and redo valves, coronary artery disease, and atrial fibrillation through the use of open, endovascular, minimally invasive, and transcatheter treatment therapies. In particular, he treats patients with aneurysms of the aortic root, ascending aorta, aortic arch, descending thoracic aorta, and thoracoabdominal aorta, in addition to anomalous coronaries, hypertrophic cardiomyopathy, endocarditis.
As a national proctor for the Convergent Procedure for minimally invasive treatment of atrial fibrillation, Dr. Shults has performed one of the highest volumes in the country and gives lectures nationwide to other physicians about the procedure.
Dr. Shults is a member of the Society of Thoracic Surgeons, the American Medical Association, the Southern Thoracic Surgical Association, the International Society for Minimally Invasive Cardiothoracic Surgery, and a fellow of the American College of Surgeons. Dr. Shults recently served as interim chair of Cardiac Surgery between 2019 and 2021.
After receiving his medical degree from Georgetown University School of Medicine, Dr. Shults completed a residency in general surgery at MedStar Georgetown University Hospital-Washington Hospital Center. During this time, he spent a year at Harvard Medical School for a research fellowship at Massachusetts General Hospital, where he focused on developing novel strategies to treat patients in hemorrhagic shock. He then returned to MedStar Washington Hospital Center as chief resident of general surgery. After this, Dr. Shults continued his specialty training in Cardiothoracic Surgery at Emory University, where he completed a three-year specialized fellowship focusing on revascularization, complex aortic disease, valvular and transcatheter valvular therapies, as well as all other aspects of cardiac surgery. Next, he traveled to Leipzig, Germany for a visiting fellowship in minimally invasive/transcatheter aortic valve repair at the University of Leipzig Heart Hospital. He returned to the U.S. for an aortic surgery mini-fellowship at the University of Texas-Houston Memorial Hermann Hospital and an endovascular mini-fellowship at the Arizona Heart Hospital Department of Heart & Vascular Surgery.
Dr. Shults takes interest in healthcare reform, healthcare economics, and innovations for minimally invasive or transcatheter therapies. His research efforts include treatment outcomes for complex aortic disease, valvular heart disease, atrial fibrillation, and coronary artery disease. Dr. Shults is currently enrolling patients in several unique clinical trials, including the use of GORE® TAG® TBE, thoracic endoprosthesis in the treatment of lesions of the aortic arch and descending thoracic aorta; GORE® TAMBE, thoracoabdominal branch endoprosthesis for the treatment of thoracoabdominal and pararenal aortic aneurysms; NeoChord artificial chordae delivery system, a mitral valve repair technique for patients with severe mitral regurgitation; a new stent for the endovascular treatment of arch aneurysms; Allergan/Botox® study to evaluate the efficacy and safety of Botox for the treatment of atrial fibrillation; as well as several trials involving the latest in transcatheter valve technology. Additionally, he is principal investigator for the Bolton Medical acute complicated type B thoracic aortic dissection clinical trial.
MedStar Medical Group
110 Irving Street Northwest
MHVI-1st Floor North Addition
Washington, DC, 20010
top of page
bottom of page